论文部分内容阅读
迁延性乙型肝炎表面抗原(HBsAg)携带者目前还未有满意的治疗方法。一般认为,HBsAg携带现象与机体对HEsAg的免疫耐受性或免疫缺陷有关,
There is currently no satisfactory treatment for persistent hepatitis B surface antigen (HBsAg) carriers. It is generally believed that the phenomenon of HBsAg carrier and the body’s immune tolerance to HEsAg or immune deficiency,